{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:18:05Z","timestamp":1785842285928,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.prp.2022.153919","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T12:43:35Z","timestamp":1651149815000},"page":"153919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["YTHDF2 is a novel diagnostic marker of endometrial adenocarcinoma and endometrial atypical hyperplasia\/ intraepithelial neoplasia"],"prefix":"10.1016","volume":"234","author":[{"given":"Piao-piao","family":"Bian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-ping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-tang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2022.153919_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2022.153919_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/PGP.0b013e31823ff422","article-title":"Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion","volume":"31","author":"Quick","year":"2012","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2022.153919_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/PGP.0b013e3182158944","article-title":"Cytokeratin 19 expression in normal endometrium and in low-grade endometrioid adenocarcinoma of the endometrium","volume":"30","author":"Stewart","year":"2011","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2022.153919_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2559.2011.03893.x","article-title":"Fascin expression in low-grade uterine endometrioid adenocarcinoma: correlation with microcystic, elongated and fragmented (MELF)-type alteration at the deep invasive margin","volume":"59","author":"Stewart","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2022.153919_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/1066896908329585","article-title":"Diffusely infiltrating endometrial carcinomas with no stromal response: report of a series, including cases with cervical and ovarian involvement and emphasis on the potential for misdiagnosis","volume":"18","author":"Kalyanasundaram","year":"2010","journal-title":"Int. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153919_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.pgp.0000233165.56385.0b","article-title":"Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma","volume":"26","author":"Ali","year":"2007","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2022.153919_bib7","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-10-0149","article-title":"Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer","volume":"70","author":"Monte","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2022.153919_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ygyno.2006.08.044","article-title":"COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma","volume":"104","author":"Erkanli","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2022.153919_bib9","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1097\/PAS.0b013e3182889dc3","article-title":"Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma","volume":"37","author":"Mao","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153919_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/PGP.0000000000000106","article-title":"Heart and neural crest derivatives expressed transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and type I endometrial carcinoma","volume":"34","author":"Buell-Gutbrod","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2022.153919_bib11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cell.2015.04.010","article-title":"N6-methyldeoxyadenosine marks active transcription start sites in Chlamydomonas","volume":"161","author":"Fu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.prp.2022.153919_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13048-020-00717-5","article-title":"YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells","volume":"13","author":"Li","year":"2020","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.prp.2022.153919_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-021-01340-8","article-title":"FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2","volume":"20","author":"Xu","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2022.153919_bib14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2018.11.006","article-title":"YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma","volume":"442","author":"Zhong","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2022.153919_bib15","article-title":"YTHDF2 inhibits gastric cancer cell growth by regulating FOXC2 signaling pathway","volume":"11","author":"Shen","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.prp.2022.153919_bib16","article-title":"Simple method for constructing and repairing tissue microarrays using simple equipment","volume":"49","author":"Zhang","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.prp.2022.153919_bib17","article-title":"Expression of TMEM16A in colorectal cancer and its correlation with clinical and pathological parameters","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2022.153919_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bjc.6604102","article-title":"Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan","volume":"98","author":"Lacey","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2022.153919_bib19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2022.153919_bib20","first-page":"160","article-title":"Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma","volume":"31","author":"Xiong","year":"2010","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.prp.2022.153919_bib21","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1158\/0008-5472.CAN-14-0108","article-title":"Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues","volume":"74","author":"Mutter","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2022.153919_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/PGP.0000000000000185","article-title":"Pax2 expression in simultaneously diagnosed WHO and EIN classification systems","volume":"34","author":"Joiner","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2022.153919_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/PGP.0b013e318226b376","article-title":"PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia","volume":"31","author":"Allison","year":"2012","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2022.153919_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/cjp2.22","article-title":"Increased proliferation in atypical hyperplasia\/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors","volume":"1","author":"Ayhan","year":"2015","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.prp.2022.153919_bib25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/ajcp\/aqw021","article-title":"IFITM1 is superior to CD10 as a marker of endometrial stroma in the evaluation of myometrial invasion by endometrioid adenocarcinoma","volume":"145","author":"Busca","year":"2016","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2022.153919_bib26","first-page":"765","article-title":"Well differentiated endometrioid adenocarcinoma of the endometrium with \u201cAdenoma Malignum-Like\u201d pattern of invasion: report of two cases and review of literature","volume":"47","author":"Assylbekova","year":"2017","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.prp.2022.153919_bib27","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2022.153919_bib28","first-page":"255","article-title":"[Knockdown of YTH N6-methyladenosine RNA binding protein 2 (YTHDF2) inhibits cell proliferation and promotes apoptosis in cervical cancer cells]","volume":"36","author":"Li","year":"2020","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"10.1016\/j.prp.2022.153919_bib29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-020-01267-6","article-title":"YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2022.153919_bib30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41374-021-00543-3","article-title":"N-methyladenosine reader YTHDF2-mediated long noncoding RNA FENDRR degradation promotes cell proliferation in endometrioid endometrial carcinoma","volume":"101","author":"Shen","year":"2021","journal-title":"Lab. Investig."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822001637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822001637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:52:33Z","timestamp":1759733553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822001637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":30,"alternative-id":["S0344033822001637"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.153919","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"YTHDF2 is a novel diagnostic marker of endometrial adenocarcinoma and endometrial atypical hyperplasia\/ intraepithelial neoplasia","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.153919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153919"}}